Recall: JAMP Rabeprazole 10mg Over-sized delayed release tablets
Last updated
Summary
Product
JAMP Rabeprazole - 10mg delayed-release Tablet
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot numbers |
|---|---|---|---|---|---|
Jamp Pharma |
JAMP Rabeprazole |
DIN 02415283 |
Tablet (Delayed Release) |
RABEPRAZOLE SODIUM - 10mg |
EG23RJA002 |
Issue
Affected lot contains over-sized delayed-release tablets.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product safety complaints to the recalling company or market authorization holder.
- Return affected product to your local pharmacy or place of purchase for proper disposal.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Jamp Pharma
1310 Nobel
Boucherville, QC
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Identification number
RA-75902
Get notified
Receive notifications for new and updated recalls and alerts by category.